Massachusetts General Hospital Thoracic Oncolgoy — Boston, Massachusetts

Massachusetts General Hospital Thoracic Oncolgoy is a clinical research site located in Boston, Massachusetts, United States 02115.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Massachusetts General Hospital Thoracic Oncolgoy has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: ALK-positive NSCLC.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Massachusetts General Hospital Thoracic Oncolgoy?

Massachusetts General Hospital Thoracic Oncolgoy has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Massachusetts General Hospital Thoracic Oncolgoy conducted?

Massachusetts General Hospital Thoracic Oncolgoy has 1 clinical trials on record, with 1 currently active. Their work covers ALK-positive NSCLC.

Is Massachusetts General Hospital Thoracic Oncolgoy accredited by Crixeo Health?

Massachusetts General Hospital Thoracic Oncolgoy has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Massachusetts General Hospital Thoracic Oncolgoy?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.